Search

everythinglearnresearchcommunity

for

Search:↓

Probiotic supplements may help reduce inflammation and oxidative stress in women with PCOS.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Medroxyprogesterone acetate injections are more effective than topical ointment in treating excessive hair growth in women.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Hormonal birth control can cause skin issues, but low-dose options and those with antiandrogens may reduce these effects.

Cyproterone and finasteride reduced hypersexuality but caused serious side effects.

Ovarian wedge resection helped regulate menstrual cycles but didn't significantly change hormone levels or hair growth in polycystic ovary syndrome.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

The steroids allopregnanolone and allotetrahydrodeoxycorticosteron worsened absence seizures in rats.

Women with PCOS often have severe PMS, but managing anemia and regular menstruation can help reduce symptoms.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Medroxyprogesterone acetate iontophoresis safely and effectively reduces facial hair growth in women.

Many women removed the Norplant implant early due to side effects like headaches and irregular bleeding, indicating a need for better patient counseling.

Neurosteroids play a key role in controlling the brain-adrenal gland activity in pregnant sheep, both in normal and stressful situations.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.